Error: Could not add to watchlist. X

Seattle Genetics Inc

+ Watchlist
SGEN:US
NASDAQ GS
47.65
USD
0.17
0.36%
As of 20:10:00 ET on 07/03/2015.
Open
48.00
Day Range
47.40 - 48.67
Volume
788,278
Previous Close
47.82
52Wk Range
30.05 - 49.84
1 Yr Return
23.29%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.66
Market Cap (b USD)
5.951
Shares Outstanding (m)
124.887
Price/Sales (TTM)
19.62
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.
ADDRESS
21823 30th Drive SE
Bothell, WA 98021
United States
PHONE
1-425-527-4000
  • Clay B Siegall
    Chairman/Pres/CEO/Co-Founder
  • Todd E Simpson
    Chief Financial Officer
  • Eric L Dobmeier
    COO/Secretary
  • Jean I Liu
    Exec VP:Legal Affairs/Gen Counsel/Secy
  • Jonathan Drachman
    Exec VP:Research & Dev
Show More